Smith, Kenneth J.; Roberts, Mark S. - In: PharmacoEconomics 18 (2000) 2, pp. 95-104
Antiviral treatment of herpes zoster is controversial because of uncertain benefits and relatively high costs. Most studies show that antiviral therapy lessens acute herpes zoster symptoms and postherpetic neuralgia (PHN). Current clinical recommendations support antiviral treatment of severely...